UNSPSC 51162319: Acetaminophen/diphenhydramine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162319 Acetaminophen/diphenhydramine/phenylephrine is a Commodity code that encompasses pharmaceutical products for state and local government procurement, though recent opportunities show divergence from the code's nominal scope. State and local buyers under this code include departments of corrections, county health and community services agencies, and other public health entities. The Washington State Department of Corrections solicited parenteral products, services, and equipment (RFQQK13020, RFQ, due October 7, 2026) including parenteral nutrition solutions, intravenous solutions, and controlled substances for incarcerated individuals across eight facilities, with multiple contractors anticipated for award by region and fixed pricing required through the initial two-year term. Seminole County, Florida issued a separate procurement for naloxone and drug deactivation systems (IFB60459723LAS, IFB, due July 26, 2023) in support of community health initiatives.

Recent activity centers on Washington and Florida, with the Washington State Department of Corrections representing a significant volume buyer serving eight regional correctional facilities across West, Central, and East regions of the state. The Seminole County opportunity specifies annual quantities of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, indicating recurring transactional volume in public health supply. Both opportunities require bidders to maintain specified insurance coverage, comply with drug-free workplace and E-Verify requirements, and meet state licensing and clearance standards. The code shows mixed recent procurement focus — while nominally designated for a specific acetaminophen combination product, actual state and local solicitations center on broader parenteral and emergency pharmaceutical supplies rather than the single-entity formulation the code name suggests.